CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $405,500
- in 5 filings
Net −$405,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-18 | Bjork Elisabeth Director | Grant or award | +30,000 | 30,000 | ||
| 2025-06-18 | SOUTHWELL DAVID P Director | Grant or award | +30,000 | 31,660 | ||
| 2025-05-20 | Militello John See Remarks | Sale | −357 | $6.45 | $2K | 64,027 |
| 2025-05-20 | Schwartz Jonathan David See Remarks | Sale | −801 | $6.45 | $5K | 235,255 |
| 2025-05-20 | Patel Kinnari See Remarks | Sale | −767 | $6.45 | $5K | 441,927 |
| 2025-05-20 | Shah Gaurav CEO | Sale | −2,253 | $6.45 | $15K | 786,806 |
| 2025-05-20 | Wilson Martin General Counsel | Sale | −587 | $6.45 | $4K | 149,163 |
| 2025-05-16 | Militello John See Remarks | Sale | −655 | $6.53 | $4K | 64,384 |
| 2025-05-16 | Patel Kinnari See Remarks | Sale | −1,409 | $6.53 | $9K | 442,694 |
| 2025-05-16 | Schwartz Jonathan David See Remarks | Sale | −1,582 | $6.53 | $10K | 236,056 |
| 2025-05-16 | Shah Gaurav CEO | Sale | −3,621 | $6.53 | $24K | 789,059 |
| 2025-05-16 | Wilson Martin General Counsel | Sale | −946 | $6.53 | $6K | 149,750 |
| 2025-04-22 | Militello John See Remarks | Sale | −718 | $7.16 | $5K | 65,039 |
| 2025-04-10 | Shah Gaurav CEO | Purchase | +20,000 | $5.08 | $102K | 792,680 |
| 2025-04-09 | Patel Kinnari See Remarks | Purchase | +21,099 | $4.70 | $99K | 26,774 |
| 2025-04-04 | Ondrey Aaron Chief Financial Officer | Sale | −7,489 | $5.29 | $40K | 129,650 |
| 2025-03-05 | Dolsten Mikael Director | Other acquisition | +14,220 | 14,220 | ||
| 2025-02-25 | Schwartz Jonathan David See Remarks | Sale | −6,532 | $10.58 | $69K | 237,638 |
| 2025-02-21 | Patel Kinnari See Remarks | Sale | −6,078 | $10.58 | $64K | 444,103 |
| 2025-02-21 | Wilson Martin General Counsel | Sale | −3,222 | $10.58 | $34K | 150,696 |
Page 7 of 9 · 164 trades